BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30911001)

  • 1. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
    Yu X; Hu L; Li S; Shen J; Wang D; Xu R; Yang H
    Cell Death Dis; 2019 Mar; 10(4):280. PubMed ID: 30911001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p.
    Jin H; Wang H; Jin X; Wang W
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34328197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA TUG1 promotes malignant progression of osteosarcoma by enhancing ZBTB7C expression.
    An X; Wu W; Wang P; Mahmut A; Guo J; Dong J; Gong W; Liu B; Yang L; Ma Y; Xu X; Chen J; Cao W; Jiang Q
    Biomed J; 2023 Aug; 47(3):100651. PubMed ID: 37562773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR675-5p Acts on HIF-1α to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma.
    Lo Dico A; Costa V; Martelli C; Diceglie C; Rajata F; Rizzo A; Mancone C; Tripodi M; Ottobrini L; Alessandro R; Conigliaro A
    Theranostics; 2016; 6(8):1105-18. PubMed ID: 27279905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA taurine upregulated gene 1 in liver disease.
    Fan Z; Pan H; Qu N; Wang X; Cao L; Chen L; Liu M
    Clin Chim Acta; 2024 Jun; 560():119752. PubMed ID: 38821337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).
    Baliou S; Kyriakopoulos AM; Spandidos DA; Zoumpourlis V
    Int J Oncol; 2020 Sep; 57(3):631-664. PubMed ID: 32705269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of long non-coding RNAs in osteosarcoma.
    Liao X; Wei R; Zhou J; Wu K; Li J
    Front Mol Biosci; 2024; 11():1327459. PubMed ID: 38516191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis.
    Zhou J; Lan F; Liu M; Wang F; Ning X; Yang H; Sun H
    Front Pharmacol; 2024; 15():1350187. PubMed ID: 38327979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulatory role and mechanism of lncTUG1 on cartilage apoptosis and inflammation in osteoarthritis.
    Liu NN; Huang YP; Shao YB; Fan XF; Sun HY; Wang TR; Yao T; Chen XY
    Arthritis Res Ther; 2023 Jun; 25(1):106. PubMed ID: 37340458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Long Noncoding RNAs in Prostate Cancer, Osteosarcoma, and Metastasis.
    Al-Shehri A; Bakhashab S
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma.
    Hinton K; Kirk A; Paul P; Persad S
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNAs could play a vital role in osteosarcoma treatment: Inhibiting osteosarcoma progression and improving chemotherapy resistance.
    Xiaotong S; Xiao L; Shiyu L; Zhiguo B; Chunyang F; Jianguo L
    Front Genet; 2022; 13():1022155. PubMed ID: 36726721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma.
    Xia Y; Wang D; Piao Y; Chen M; Wang D; Jiang Z; Liu B
    Front Immunol; 2022; 13():1025532. PubMed ID: 36457998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CASC9 promotes cell proliferation and invasion in osteosarcoma through targeting miR-874-3p/SOX12 axis.
    Qiu H; Yang D; Li X; Feng F
    J Orthop Surg Res; 2022 Oct; 17(1):460. PubMed ID: 36266695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging-regulated TUG1 is dispensable for endothelial cell function.
    Gimbel AT; Koziarek S; Theodorou K; Schulz JF; Stanicek L; Kremer V; Ali T; Günther S; Kumar S; Jo H; Hübner N; Maegdefessel L; Dimmeler S; van Heesch S; Boon RA
    PLoS One; 2022; 17(9):e0265160. PubMed ID: 36173935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m6A-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Osteosarcoma.
    Bi Y; Meng D; Wan M; Xu N; Xu Y; Yuan K; Liu P; Fang H; Hu H; Lan S
    Comput Intell Neurosci; 2022; 2022():9315283. PubMed ID: 35978902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Key Metabolic Regulator of Bone and Cartilage Health.
    Pérez-Hernández E; Pastrana-Carballo JJ; Gómez-Chávez F; Gupta RC; Pérez-Hernández N
    Endocrinol Metab (Seoul); 2022 Aug; 37(4):559-574. PubMed ID: 35938304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of long non-coding RNAs in angiogenesis and anti-angiogenic therapy resistance in cancer.
    Liu J; Zhang Q; Yang D; Xie F; Wang Z
    Mol Ther Nucleic Acids; 2022 Jun; 28():397-407. PubMed ID: 35505957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA regulatory networks in post-transcriptional regulation of VEGFA in cancer.
    Fontemaggi G
    IUBMB Life; 2023 Jan; 75(1):30-39. PubMed ID: 35467790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.